Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26569685 | 0.79 | CYP2C9 (0.33) | CYP2C9CYP2C19NPSR1 | |
| SCHEMBL26569676 | 0.74 | CRHR1 (0.35) | KDM4EPKMCYP2C9CYP2C19NPSR1 | |
| SCHEMBL26569656 | 0.72 | PDE10A (0.53) | KDM4EPKMCYP2C19ALDH1A1 | |
| SCHEMBL13336153 | 0.70 | NOS3 (0.31) | — | |
| SCHEMBL26733460 | 0.67 | CYP1A2 (0.34) | KDM4ECYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL25938679 | 0.67 | TDP1 (0.41) | KDM4EALDH1A1 | |
| SCHEMBL20457069 | 0.67 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12169342 | 0.66 | NOS3 (0.50) | KDM4EALDH1A1 | |
| SCHEMBL24928215 | 0.64 | CYP1A2 (0.35) | KDM4ECYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL317299 | 0.62 | RAPGEF4 (0.50) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OCIAD2, OCIAD1 | KDM4E 3832/4885PKM 2937/4885CYP2C9 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.